Introduction 1 2
Mini-transposon vectors allow for the stable insertion of foreign DNA into the chromosome of many 3 types of Gram-negative bacterial targets (1,2). Tn5-derived elements (3) present clear advantages over 4 the use of their plasmid-based counterparts for the random interruption of gene(s), or for the 5 introduction and expression of heterologous genes into several bacterial species. These features 6
include, but are not limited to, (i) maintenance of the corresponding transgenes without antibiotic 7 selective pressure, (ii) long-term stability of the constructs and re-usability of the functional DNA parts, 8 and, furthermore, (iii) mini-Tn5-based vectors admit cloning and chromosomal delivery of considerably 9 long DNA fragments (which would be cumbersome to manipulate in other DNA delivery tools). As the 10 transposase gene tnpA is lost following each transposition event (4,5), one added value of mini-Tn5 11
vectors is the possibility to use them recursively in the same microbial host, provided that they bear 12 different selection markers. Since the TnpA transposase tends to act in cis (6), it promotes the insertion 13 of DNA sequences borne by the plasmid irrespective of any previous DNA insertions in a given 14 chromosome. These features allow for the delivery and integration of various DNA cargoes into the 15 same target genome. However, the original layout of such mini-transposon vectors was not exempt of 16 downsides. One of them is the unavoidable inheritance of long, non-functional DNA fragments 17 stemming from the intricate cutting-and-pasting DNA methods available at the time when the original 18 vectors were constructed. These procedures were also afflicted by the presence of an excessive and 19 inconvenient number of non-useful restriction sites scattered along the plasmids, and the suboptimal 20 transposition machinery encoded therein. improving their functionality and making them entirely modular and exchangeable. The final product 28 was the entirely synthetic plasmid construct termed pBAM1 (born-again mini-transposon). This design 29 was soon followed by a series of synthetic, modular broad-host-range mini-Tn5 plasmids derived from 30 pBAM1. These vectors, termed pBAMDs vectors (9), enable the possibility of easy cloning and 31 represents any nucleotide. (ii) ME-O-Km-Int-F: 5'-ATC TGA TGC TGG ATG AAT TTT TC-3'. This primer 31 is used in arbitrary PCR, round 2, and for sequencing to map the integration 1 point (9). 2 3 pBAMD1-4 (i) ME-O-Sm-Ext-F: 5'-CTT GGC CTC GCG CGC AGA TCA G-3'. This primer 4 is used in arbitrary PCR, round 1 (9). 5
(ii) ME-O-Sm-Int-F: 5'-CAC CAA GGT AGT CGG CAA AT-3'. This primer is 6 used in arbitrary PCR, round 2, and for sequencing to map the integration 7 point (9). 8 9 pBAMD1-6 (i) ME-O-Gm-Ext-F: 5'-GCA CTT TGA TAT CGA CCC AAG T-3'. This primer 10 is used in arbitrary PCR, round 1 (9). 11
(ii) ME-O-Gm-Int-F: 5'-TCC CGG CCG CGG AGT TGT TCG G-3'. This primer 12 is used in arbitrary PCR, round 2, and for sequencing to map the integration 13 point (9). 14 15 pBELG and pBELK (i) pBEL-ME-O-Ext-F: 5'-CTG CGA CAT CGT ATA ACG TTA CTG GTT TC-3'. 16
This primer is used in arbitrary PCR, round 1 (10). 17
(ii) pBEL-ME-O-Int-F: 5'-GGG CGC TAT CAT GCC ATA CCG-3'. This primer 18 is used in arbitrary PCR, round 2 (10). This primer is used in arbitrary PCR, round 1 (10). 22
(ii) pBEX-ME-O-Int-F: 5'-CCT TCC GAC ACC CTG CGT CAA TG-3'. This 23 primer is used in arbitrary PCR, round 2 (10). 24 25 2.5.3. Primers specific to the ME-I end of each mini-transposon 26 27 pBAMD1-2 (i) pBAM-ME-I-Ext-R: 5'-CTC GTT TCA CGC TGA ATA TGG CTC-3'. This 28 primer is used in arbitrary PCR, round 1 (7). 29
(ii) pBAM-ME-I-Int-R: 5'-CAG TTT TAT TGT TCA TGA TGA TAT A-3'. This 30 primer is used in arbitrary PCR, round 2, and for sequencing to map the 31 integration point (7). 1 2 pBAMD1-4 (i) ME-I-Sm-Ext-R: 5'-ATG ACG CCA ACT ACC TCT GAT A-3'. This primer 3 is used in arbitrary PCR, round 1 (9). 4
(ii) ME-I-Sm-Int-R: 5'-TCA CCG CTT CCC TCA TGA TGT T-3'. This primer 5 is used in arbitrary PCR, round 2, and for sequencing to map the integration 6 point (9). 7 8 pBAMD1-6 (i) ME-I-Gm-Ext-R: 5'-GTT CTG GAC CAG TTG CGT GAG-3'. This primer 9 is used in arbitrary PCR, round 1 (9). 10
(ii) ME-I-Gm-Int-R: 5'-GAA CCG AAC AGG CTT ATG TCA-3'. This primer 11 used in arbitrary PCR, round 2, and for sequencing to map the integration 12 point (9). 
24
When employing the specialized pBELs or pBEXs mini-Tn5 vectors (10), the presence or the absence 25 of antibiotic resistance genes can be easily assessed by colony PCR with primers cFRT-Ab-R (5'-GAG 26 AAT AGG AAC TTC GGA ATA GG-3') in combination with either cKm-F (5'-CGG AAT GCT ATG CAG 27 ACG-3', when using pBELK or pBEXK) or cGm-F (5'-CCC GTA TGC CCA ACT TTG-3', when using 28 pBELG or pBEXG). The corresponding expected amplicon lengths are 736 bp (for pBELG and pBEXG) 29 and 535 bp (for pBELK and pBEXK). 30 31 2.5. Other laboratory material and equipment and standard procedures 1 2 1. Bacteria are routinely grown aerobically in 10-mL plastic test tubes (e.g., 16×100 mm, round 3 bottom tubes; E&K Scientific Products Inc., Santa Clara, CA, USA) containing 3 mL of the 4 corresponding liquid culture medium. P. putida KT2440 is incubated at 30°C and E. coli strains are 5 incubated at 37°C with rotary agitation at 170 rpm. 6 2. For electroporation, 2-mm gap width cuvettes (e.g., Gene Pulser TM /Micropulser™ electroporation 7 cuvettes; Bio-Rad Laboratories Inc., Hercules, CA, USA) and a bacterial electroporation system 8 (e.g., MicroPulser™; Bio-Rad Laboratories Inc.) are used. 
Methods 24 25
The mini-transposon vectors described in the present protocol have two principal uses: (i) the 26 generation of libraries of random mutants to correlate a particular and observable phenotype to a 27 specific gene (1,7,8,24) ; or (ii) the introduction of heterologous gene(s) randomly into the chromosome 28 of a target Gram-negative bacterium (2,9,10). In the first application, a typical random mutagenesis 29 protocol involves three steps: (i) delivery of the non-replicative plasmid bearing the mini-transposon 30 into a recipient strain, (ii) selection of transconjugants carrying the transposon, and (iii) storing the 31 library for future uses or directly identifying the insertion point of the mini-transposon in the genome of 1 selected recipient cells. In the second case, when the objective is to introduce heterologous DNA into a 2 bacterial genome, a previous step is included in which the gene (or genes) of interest has to be cloned 3 into the multiple cloning site of the mini-Tn5 delivery plasmid. Steps (i), (ii), and (iii) are then followed 4 as described in the specific procedure below. Finally, when using any of the pBELs or pBEXs mini-Tn5 5 plasmids (10) to deliver a DNA cargo under a controlled expression system, a final extra step is added 6 ad libitum to remove the antibiotic marker of the mini-Tn5 cassette. 7
8
The first step of the protocol (i.e., introduction of the mini-transposon plasmid into the recipient strain), 9 could be done either by mating or electroporation. Specific protocols to perform either delivery 10 technique are described below, and a specific application example, in which plasmid pBAMD1-2 (9) 11 was employed to generate a library of random insertion mutants of P. putida KT2440, is discussed. 12
The main steps of the protocol are summarized in Fig. 1 . 13 14
Mini-Tn5 delivery into P. putida by conjugation 15 16
Whenever possible, we recommend to use this delivery method since it is more efficient than 17 electroporation of plasmids. Conjugation requires cell contact to transfer DNA from a donor cell to a 18 recipient strain. To establish such intimate contact, donor bacteria produce the conjugative pilus (i.e., a 19 type IV secretion system) that ultimately retracts, bringing both cells together. A number of proteins of 20 the donor bacterial cell form a bridge between both donor and recipient cells forming a mating pair (i.e., 21
Mpf proteins, for mating pair formation). Then, the relaxosome (i.e., a complex formed by a relaxase 22 To perform a conjugation experiment, one just needs to bring together the donor cell (i.e., bearing the 27 mini-transposon plasmid), the recipient cell (i.e., the target bacterium), and a helper bacterial strain to 28 assist and catalyze the mating process. The mating helper is an E. coli strain that provides the 29 conjugation machinery. Typically, this molecular machinery is derived from the IncPα plasmid RP4 30 (also known as RK2 or RP1), and involves the mobilization (mob) and transfer (tra) functions (27,28), 31 supplied in trans. There are two basic types of helper strains, which express the mob/tra functions 1 either (i) in a plasmid (e.g., E. coli HB101 carrying plasmid pRK600; Table 1 and 2), or (ii) integrated in 2 the genome (e.g., E. coli S17-1 λpir, E. coli SM10 λpir, or E. coli MFD λpir; Table 1 ). When using the 3 former type of helper E. coli strain, the user needs to include three bacterial strains in the mating 4 process (i.e., setting up a triparental mating). A triparental mating offers the possibility of changing the 5 donor E. coli strain (which should contain the pir gene as a λpir lysogen, e.g., E. coli CC118 λpir or 6 DH5α λpir) in order to favor counter selection of transconjugants as needed. In the case of performing 7 a biparental mating, the protocol is exactly the same as per the triparental mating procedure, but using 8 only two bacterial strains in the mixture (i.e., the recipient strain and the mobilizing donor cell, that in 9 addition to the mini-Tn5 plasmid also has the mob/tra functions integrated in the genome). 10
11
As indicated above, in the present protocol we describe a triparental mating using P. putida KT2440 as 12 the recipient strain and pBAMD1-2 as the mini-Tn5 delivery plasmid (9). In order to properly generate a 13 random mutagenesis library when working with other recipient bacterial species, it is important to 14 perform several previous tests to determine the optimal experimental conditions for successful DNA 15 (ii) Mating helper: E. coli HB101 (carrying plasmid pRK600) grown in LB medium added with Cm 26 at 30 µg/ml. Incubate for 18 h at 37ºC with rotary agitation. This bacterium provides the plasmid 27 with the mobilization (mob) and transfer (tra) functions, encoded in plasmid pRK600. 28 (iii) Recipient: P. putida KT2440 grown in LB medium at 30ºC with rotary agitation (see Note 5). 29 2. Measure the optical density at 600 nm (OD600) of the bacterial cultures and adjust the bacterial 30 suspensions to an OD600 of 1 with PBS in a final volume of 1 mL in a 1.5-mL Eppendorf tube. 31 3. Centrifuge the cultures at 7200×g for 2 min at room temperature, discard the supernatant, and re-1 suspend the sediment in 1 mL of 10 mM MgSO4 to wash the cells. with a sterile toothpick). Let the cells grow overnight (e.g., 18-24 h) aerobically (170 rpm) at 30ºC. 27 2. Transfer the saturated culture to a 50-mL Falcon tube and centrifuge it at 3220×g for 10 min at 28 room temperature. 29 3. Discard the supernatant, add 10 mL of 300 mM sucrose and softly resuspend the cell sediment; 30 then, centrifuge the suspension at 3220×g for 10 min at room temperature. 31 4. Remove the supernatant and add 1 mL of 300 mM sucrose, resuspend the cells, and transfer the 1 suspension to a 2-mL sterile Eppendorf tube. Centrifuge at 7200×g for 3 min at room temperature. 2 5. Remove the supernatant, add 800 µL of 300 mM sucrose, resuspend the cells, and centrifuge the 3 suspension at 7200×g for 3 min at room temperature. Repeat this washing step once more. 4 6. Remove the supernatant and add 500 µL of 300 mM sucrose to resuspend the sediment and to 5 obtain a concentrated cell suspension (after the final resuspension step, the concentration of 6 electrocompetent bacteria should be ≈ 5×10 10 cells/mL). 7 8. Transfer 100 µL of the electrocompetent cell suspension to a 1.5-mL sterile Eppendorf tube and 8 add ≈ 500 ng of plasmid pBAMD1-2 (in < 10 µL). Pipet the plasmid DNA-cell suspension mix to a 9 2-mm gap width electroporation cuvette. Care has to be taken to avoid the formation of bubbles at 10 this step, which would reduce the overall efficiency of the electroporation process. This process is aimed to differentiate between genuine transposition events (i.e., Km R colonies) 28 from spurious mini-Tn5 plasmid co-integration incidents (i.e., Km R and Ap R colonies). Incubate the 29 plates overnight at 30ºC. 30 2. Select Km R and Ap S clones. Also, use colony PCR amplifications with oligonucleotides PS4 and 31 PS5 to confirm the absence of the delivery plasmid backbone. 1 3. Re-streak selected colonies several times onto M9 minimal medium plates containing 0.2% (w/v) 2 citrate and 50 µg/mL Km to make sure of working with pure isolated clones. onto LB medium plates (with the appropriate antibiotics as necessary) overnight, and adding 2 mL 6 of 20% (v/v) glycerol in LB medium thereafter. Cells are gently scrapped from the surface by using 7 a sterile glass rod (i.e., a Drigalski spatula). One mL of the resulting suspension is then transferred 8 into a cryotube (e.g., a 1.8-mL Nunc TM CryoTubes TM cryogenic vial, round bottom). Cells can be 9 stored at -80°C under these conditions for several years without significant loose of viability, 10 provided that the bacterial stock is not repeatedly frozen and thawed. 11 6. Take mutant clones from the frozen stock and streak the cells onto LB medium agar plates 12 containing 50 µg/mL Km. Grow the cells overnight at 30°C. 11. Distribute 9.7 µL of the PCR reaction mix into each PCR tube. 31 12. The primers needed for round 1 of the arbitrarily primed PCR amplification are ARB6 together with 1 the external ME-I or ME-O primers (i.e., either ME-I-Ext or ME-O-Ext). 14. Directly take 1 µL of the PCR after running round 1 (i.e., no need to check for positive 7 amplifications in an agarose gel) and use it as the template for round 2 of arbitrary PCR. In this 8 round, use primer ARB2 together with the internal ME-I or ME-O primers (i.e., either ME-I-Int or 9 ME-O-Int) (see Note 13). Prepare the PCR reaction mix for round 2 as indicated in step 8 above. under the control of an expression system (i.e., LacI Q /Ptrc or XylS/Pm) (10), the genes conferring 31 resistance to Km (aphA) or Gm (aacC1) in these transposons can be removed as they are flanked by 1 FLP recombinase target (FRT) sequences (38). This layout offers the possibility to the user of 2 eliminating that marker by means of ectopic expression of the FLP recombinase from Saccharomyces 3 cerevisiae using plasmid pFLP2 ( Table 2 ). The expression of the FLP recombinase in plasmid pFLP2 4 is driven by the strong, rightward λ promoter (located within the FLP-cI857 intergenic region) and is 5 regulated by the temperature-sensitive, cI857-encoded λ repressor (39). 6 7 1. Select a transconjugant P. putida clone in which the insertion place of the mini-transposon has 8 been successfully localized. 9 2. Introduce plasmid pFLP2 (see Note 16) into this selected clone by either mating or electroporation 10 as described above. 11
3. Plate the cells on M9 minimal medium plates added with sodium citrate at 0.2% (w/v) and Cb at 12 500 µg/mL. Incubate the plates overnight at 30ºC. If no discernible colonies are observed after this 13 incubation period, try lowering the Cb concentration to 350 µg/mL. 14 4. Select two or three independent colonies and re-streak them on M9 minimal medium plates added 15 with sodium citrate at 0.2% (w/v) and Cb at 500 µg/mL. Incubate the plates overnight at 30ºC. sodium citrate plus Cb at 500 µg/mL. 27 9. Select Cb-sensitive clones and store them as frozen stocks at -80ºC. 28
Preparing and storing a mutant library of mini-Tn5 insertions in P. putida 1 2
After obtaining a random mutagenesis library, it is always useful to save it for later analyses. The steps 3 below indicate the procedure to store the library after introduction of plasmid pBAMD1-2 in strain 4 KT2440 as explained in the preceding sections. 2. Avoid repeated freezing and thawing of antibiotic solutions as they may lose effectiveness. We 24 routinely distribute the stock solutions in 0.5-mL working aliquots that are used just a couple of 25 times before discarding them. 26 3. If no amplification is obtained through colony PCR, genomic DNA can be isolated with a 27 commercial kit (e.g., UltraClean TM Microbial DNA isolation kit; MoBio Laboratories Inc., Carlsbad, 28 CA, USA) and used as the template for amplifications. 29 4. It is very important to grow the donor bacterial strain in the presence of the antibiotic for which the 30 plasmid backbone carries a resistance gene (e.g., Ap) to avoid inadvertent selection of transposed 31 donor cells. Note that there is a vector derived from pBAM1 which carries a promoterless gfp gene 1 (plasmid pBAM1-GFP), which allows for the visual inspection of successful gene::gfp fusions after 2 the transposition event. 3 5. In some cases, incubating the recipient strain at high temperatures (40ºC-42ºC) for a few hours 4 before mating is known to increase the efficiency of the process by inactivating its endogenous 5 DNA restriction machinery. 6 6. Different ratios of the bacterial strains to be included in the triparental mating could also be tested if 7 needed (e.g., by increasing the amount of donor cells). To do this, simply adjust the volume of 8 each bacterial suspension appropriately with 10 mM MgSO4 to bring the final volume to 5 mL, and 9 proceed as indicated. In the case of integrating DNA cargoes into the bacterial genome, where 10 there is no need of the high numbers of transconjugant colonies usually required for random 11 mutant libraries, one can use just 100 µL of each overnight cultures (i.e., without adjusting the 12 OD600 of the individual cultures). 10. It is also important to plate (i) the donor strain, (ii) the mating helper, and (iii) the recipient strain 25 onto the selective culture medium used to recover transconjugants. These three bacterial strains 26
should not grow in the selective culture medium (i.e., they are used as negative controls). 27 11. Take into account that different mini-Tn5-bearing plasmids need other antibiotics (e.g., Sm at 80 28 µg/mL or Gm at 10 µg/mL in the case of plasmids pBAMD1-4 and pBAMD1-6, respectively) to 29 select for positive transconjugants. 30 12. Note that the specific ME primers have to be chosen depending on the mini-Tn5 plasmid used for 31 insertions and on the selected ME-end. Mini-transposon vectors can be used for delivering gene(s) into a target chromosome in virtually any 7
Gram-negative bacterium, as well as to obtain random mutant libraries. Ab R , antibiotic resistance. 8
